FDA-Drug2023-02-01Class I
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Hazard
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Sold states
Nationwide in the USA.
Affected count
321,246 tablets
Manufactured in
184 Liberty Corner Rd, N/A, Warren, NJ, United States
Products
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0181-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief